GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 10/10/2011
PIL Timentin Injection 3.2 g

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 17/02/2009 and displayed until 10/10/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to side-effects
Updated on 24/10/2008 and displayed until 17/02/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 07/08/2007 and displayed until 24/10/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to drug interactions
Updated on 26/06/2003 and displayed until 07/08/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 12/08/2002 and displayed until 26/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 10/05/2002 and displayed until 12/08/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 25/10/2000 and displayed until 10/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   potassium clavulanate
   ticarcillin sodium